Özet:

The aim was to evaluate the treatment models applied for premature retinopathy (ROP), to determine the effectiveness and results of the treatment models. Tools and Methods: Born and followed babies in our hospital between January 2012 and January 2017 and all premature babies with a need for treatment due to ROP, directed from external centers to our clinic, were evaluated as retrospective. According to the criteria determined by the International ROP Committee, the zones and stages of the events were recorded. Patients were evaluated in three groups. The group 1 is classified as "plus (plus)" disease with any stage in zone 1, the group 2 is classified as "plus" disease with stage 2 or 3, the group 3 is classified as aggressive posterior retinopathy (APROP). The incidents were recorded by the birth weight, gestation age, the treatments, the number of treatments and the weeks of application. The "plus" disease was considered a successful treatment for retardation, macular fear and the failure to develop retinal decomposition. Results: During the study period, 1746 preterm babies were examined in terms of ROP. The study included 65 (3.7%) babies, including 31 girls and 34 men. There were 126 babies in the eye. The average birth weight of babies was 1159 (535-2200) grams, the birth time was 28.4±2,5 (24-34) weeks. The group 1 contained 33 eyes (26.1%), the group 2 contained 71 eyes (56.3%), and the group 3 contained 22 eyes (17.4%). Dosan was treated three times to four eyes (%74.6) one, 26 eyes (%20.6) two and 6 eyes (%4.8). The average time for the first treatment was 36±2,4 (32-41) weeks. The first treatment was performed in group 1 (%75.8) and group 3 (%95,5) with intravitreal bevacizumab (IVB) and in group 2 (%78.9) with diod laser photokoagulation (LFK). There was a significant positive correlation between the week of birth and the birth weight and the first week of treatment. In 42.1 percent of patients with LFK and 7 percent of patients with IVB, recurrence was re-treated (p<0.05). The LFK+IVB’s 5 favourite nuts were not developed together. In the group 1 of 1 patients in the 2 eyes, stage 4a retina decomposition developed. In the group 2 of 1 patients, 2 of the eyes developed macular fever. 122 favored (96.8%) were successfully treated after the applied treatments. The result is that premature retinopathy can be controlled with appropriate and effective treatment. Although LFK in ROP is still the first treatment option; Zone 1 disease and IVB in APROP is an effective treatment option alone or with LFK. The IVB treatment model reduces the number of initiatives applied in the treatment of ROP.

Anahtar Kelimeler: